EU Digital Omnibus Simplifies AI Act Obligations; Rhode Island Enacts AI Healthcare Laws

Trending Articles
Latest Articles & News

Data Protection in Clinical Trials: Governing AI-Assisted Data Flows Under GDPR
AI intensifies clinical trial data protection, requiring end-to-end governance and inspection-ready controls.

Weekly Digest: EU AI Act Prohibitions, GDPR Enforcement and Clinical Trial Developments - Week of 22 June 2026
AI healthcare rules tighten as EU, US and GDPR developments accelerate.

CTIS Data Protection: Joint Controllership, GDPR Obligations and Sponsor Responsibilities
Understand CTIS data protection obligations under EU CTR 536/2014 and GDPR. Learn how the Joint Controllership Arrangement allocates roles among sponsors, EMA and Member States.

Pseudonymisation Clinical Trials: CNIL's Enforcement Clarifications and What They Mean for Life Sciences Organisations
CNIL's 2026 enforcement action clarifies the line between pseudonymisation and anonymisation in clinical trials. Learn the GDPR implications and recommended practices.

Weekly Privacy & AI Regulation Digest: Shadow AI, EDPB Templates, EHDS and Global Reform - Week of 16 June 2026
Shadow AI risks, EDPB breach and DPIA templates, the European Health Data Space, Canada's PIPEDA replacement and APAC consent divergence, this week's key updates.

DPIA Clinical Trials: How the EDPB Harmonised Template Reshapes Sponsor Obligations
The EDPB's 2026 harmonised DPIA template changes how sponsors conduct data protection impact assessments in clinical trials. Learn what it means for your programme.




